Skip to main content
. 2021 Feb 26;9(2):e001818. doi: 10.1136/jitc-2020-001818

Figure 1.

Figure 1

Multivariable analysis of the association between post-transplantation cyclophosphamide for GVHD prophylaxis and aGVHD, progression-free survival (PFS) and overall survival (OS). aGVHD, acute graft-versus-host disease; NS, not significant.